Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients. | Front Oncol | 2026 | 41809822 | PubTator, text mining | PubMed |
| Roles of RNA-binding proteins in macrophage function regulation and immunotherapy. | Front Cell Dev Biol | 2026 | 41808933 | PubTator, text mining | PubMed |
| Interaction between m6A and YAP1 mechanotransduction pathways is essential for mechanical memory and matrix remodeling in pancreatic cancer. | Int J Biol Sci | 2026 | 41800248 | PubTator, text mining | PubMed |
| The mechanism of Vicenin-2 in ameliorating skin photoaging: involvement of m6A-modified macrophage polarization. | Front Pharmacol | 2026 | 41800084 | PubTator, text mining | PubMed |
| Blood-based epigenetic biomarkers in rheumatoid arthritis: current knowledge and future perspectives. | Front Immunol | 2026 | 41798917 | PubTator, text mining | PubMed |
| LncRNAs: key regulators and molecular mechanisms in lung cancer radiosensitivity. | Open Med (Wars) | 2026 | 41798908 | PubTator, text mining | PubMed |
| METTL14 Aggravates Sepsis-Induced Acute Kidney Injury by Promoting Ferroptosis Through m6A Modification of BMAL1. | Clin Exp Pharmacol Physiol | 2026 | 41797341 | PubTator, text mining | PubMed |
| m⁶A-Modified hsa_circ_0002694 facilitates OSCC progression via the METTL14/YTHDC1/miR-616-3p/c-Myc axis. | Head Face Med | 2026 | 41796335 | PubTator, text mining | PubMed |
| RBM15B promotes hepatocellular carcinoma progression via IGF2BP1-mediated ITSN2 mRNA stabilization. | J Cancer Res Clin Oncol | 2026 | 41795047 | PubTator, text mining | PubMed |
| METTL14/m6A/CEBPD axis: A critical player in chronic cerebral hypoperfusion-associated neuroinflammation. | Free Radic Biol Med | 2026 | 41791683 | PubTator, text mining | PubMed |
| The expanding role of m6A RNA modification in plant-virus dynamics: friend, foe, or both? | Adv Biotechnol (Singap) | 2026 | 41790361 | PubTator, text mining | PubMed |
| The dual role of the crosstalk between autophagy and ferroptosis in lung cancer treatment: Advances in mechanisms and therapeutic strategies (Review). | Int J Mol Med | 2026 | 41789644 | PubTator, text mining | PubMed |
| Identification of FTO as a key m6A demethylase linking immune dysregulation to sepsis pathogenesis. | Front Immunol | 2026 | 41789088 | PubTator, text mining | PubMed |
| Circ_0003323 binds METTL1 to mediate KLK6 m7G methylation modification and promote the progression of colorectal cancer. | iScience | 2026 | 41782829 | PubTator, text mining | PubMed |
| Spinal motor neuron degeneration after brachial plexus avulsion: mechanisms and therapeutic targets. | Front Neurosci | 2026 | 41777735 | PubTator, text mining | PubMed |
| Correction: N6‑methyladenosine‑modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14‑dependent manner in renal cell carcinoma. | Mol Cancer | 2026 | 41776635 | PubTator, text mining | PubMed |
| Exosomes as Pivotal Mediators of Tumor-Immune Communication: Implications for Immunotherapy and Liquid Biopsy. | Int J Nanomedicine | 2026 | 41773242 | PubTator, text mining | PubMed |
| Uncovering mitochondrial dynamics-related genes as potential diagnostic biomarkers for acute myocardial infarction. | Front Cardiovasc Med | 2026 | 41768570 | PubTator, text mining | PubMed |
| The emerging role of m6A methylation in prostate-related diseases: mechanisms and clinical implications. | Front Immunol | 2026 | 41766860 | PubTator, text mining | PubMed |
| Integrated network toxicology and multi-omics analysis reveals the role of tobacco-specific carcinogen NNK in idiopathic pulmonary fibrosis pathogenesis. | Respir Res | 2026 | 41764494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=6